IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Pharmaceutical
Sub Sector: R&D driven chemical manufacturing company engaged in manufacturing of; (i) high purity advance pharmaceutical intermediates; and (ii) active pharmaceutical ingredients.
Anlon healthcare is a R&D driven chemical manufacturing company engaged in manufacturing of; (i) high purity advance pharmaceutical intermediates (Pharma Intermediate) which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients; and (ii) active pharmaceutical ingredients (APIs) which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula (FDF) such as tablet, capsules, ointment, syrup etc, ingredients in nutraceuticals formulations, personal care products and animal health products. Anlon healthcare's products spans across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API. Anlon healthcare's active pharmaceutical ingredient products are manufactured in accordance with Indian and international pharmacopeia standards such as IP, BP, EP, JP, USP. Anlon healthcare is one of the few manufacturers of loxoprofen sodium dihydrate in India, which is a notable API widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction. In addition to the manufacturing of Pharma Intermediate and APIs in accordance with various domestic and international standards, Anlon healthcare have recently started undertaking custom manufacturing services for complex or novel chemical compounds, tailoring the manufacturing process to meet specific customer requirements, including producing chemicals with purity levels that exceed industry standards. Anlon healthcare's domain knowledge and expertise enables us to reduce existing impurities and employ appropriate processes to achieve the desired level of purity.
KFin Technologies Limited
Anlon Healthcare operates in Pharmaceutical and R&D driven chemical manufacturing company engaged in manufacturing of; (i) high purity advance pharmaceutical intermediates; and (ii) active pharmaceutical ingredients.. The Issue would be listed on MainBoard. The registrar of the Issue is KFin Technologies Limited. The IPO type of Anlon Healthcare is Book Building Process and Object of issue is
Merchant Banker of Anlon Healthcare IPO is Interactive Financial Services Limited
The DRHP (Draft Red Herring Prospectus) of Anlon Healthcare IPO was filed on 09 Oct 2024.
No, Anlon Healthcare IPO is not yet listed. See other upcoming MainBoard IPOs here.
The IPO open date and IPO close date of Anlon Healthcare are not available now. You can apply in Anlon Healthcare IPO online using either UPI or ASBA as a payment method. ASBA IPO application can be done through net banking of your bank account. UPI IPO application is also offered by brokers, though they don't handle any banking services.
Why Us?
